As Johnson & Johnson’s One-Shot Covid-19 Vaccine Joins The Fight, Hesitancy Could Subside

The addition of Johnson & Johnson’s single-dose vaccine in the U. S. could spur more Americans to get immunized against Covid-19 and further reduce vaccine hesitancy, polls indicate.

Read the full post on Forbes - Healthcare